A detailed history of Candriam S.C.A. transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Candriam S.C.A. holds 18,084 shares of IDXX stock, worth $9.26 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
18,084
Previous 25,538 29.19%
Holding current value
$9.26 Million
Previous $13.8 Million 36.1%
% of portfolio
0.05%
Previous 0.09%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$468.04 - $548.53 $3.49 Million - $4.09 Million
-7,454 Reduced 29.19%
18,084 $8.81 Million
Q1 2024

May 03, 2024

SELL
$515.08 - $576.87 $4.69 Million - $5.25 Million
-9,098 Reduced 26.27%
25,538 $13.8 Million
Q4 2023

Feb 14, 2024

SELL
$391.37 - $557.56 $234,430 - $333,978
-599 Reduced 1.7%
34,636 $19.2 Million
Q3 2023

Nov 13, 2023

BUY
$432.42 - $556.67 $12.6 Million - $16.2 Million
29,154 Added 479.43%
35,235 $15.4 Million
Q2 2023

Aug 08, 2023

SELL
$450.7 - $503.61 $3.79 Million - $4.23 Million
-8,409 Reduced 58.03%
6,081 $3.05 Million
Q1 2023

May 12, 2023

SELL
$406.01 - $514.59 $913,928 - $1.16 Million
-2,251 Reduced 13.45%
14,490 $7.25 Million
Q4 2022

Feb 13, 2023

BUY
$324.64 - $441.27 $319,445 - $434,209
984 Added 6.24%
16,741 $6.83 Million
Q3 2022

Nov 10, 2022

BUY
$325.8 - $407.78 $3.13 Million - $3.92 Million
9,622 Added 156.84%
15,757 $5.13 Million
Q2 2022

Aug 03, 2022

SELL
$327.37 - $553.44 $16.6 Million - $28 Million
-50,556 Reduced 89.18%
6,135 $2.15 Million
Q1 2022

May 13, 2022

BUY
$466.52 - $631.01 $1.42 Million - $1.92 Million
3,046 Added 5.68%
56,691 $31 Million
Q4 2021

Feb 10, 2022

BUY
$586.54 - $666.48 $5.76 Million - $6.54 Million
9,819 Added 22.4%
53,645 $35.3 Million
Q3 2021

Nov 09, 2021

SELL
$621.9 - $705.76 $3.79 Million - $4.31 Million
-6,100 Reduced 12.22%
43,826 $27.3 Million
Q2 2021

Jul 20, 2021

BUY
$486.36 - $637.08 $21.2 Million - $27.8 Million
43,592 Added 688.22%
49,926 $31.5 Million
Q4 2020

Jan 22, 2021

SELL
$383.85 - $499.87 $5.23 Million - $6.81 Million
-13,622 Reduced 68.26%
6,334 $3.17 Million
Q3 2020

Oct 19, 2020

SELL
$334.54 - $406.31 $1.76 Million - $2.14 Million
-5,258 Reduced 20.85%
19,956 $7.85 Million
Q2 2020

Jul 23, 2020

BUY
$230.66 - $330.16 $4.17 Million - $5.96 Million
18,061 Added 252.5%
25,214 $8.33 Million
Q4 2019

Jan 21, 2020

BUY
$248.66 - $285.01 $337,680 - $387,043
1,358 Added 23.43%
7,153 $2,000
Q3 2019

Oct 21, 2019

SELL
$260.07 - $289.93 $98,566 - $109,883
-379 Reduced 6.14%
5,795 $2,000
Q1 2019

May 02, 2019

BUY
$178.02 - $225.69 $44,505 - $56,422
250 Added 4.22%
6,174 $1.38 Million
Q3 2018

Nov 07, 2018

BUY
$218.82 - $254.46 $63,238 - $73,538
289 Added 5.13%
5,924 $1.48 Million
Q2 2018

Aug 14, 2018

BUY
$185.56 - $227.9 $1.05 Million - $1.28 Million
5,635 New
5,635 $1.23 Million
Q1 2018

May 09, 2018

SELL
$157.81 - $204.73 $317,198 - $411,507
-2,010 Closed
0 $0
Q4 2017

Feb 07, 2018

SELL
$147.68 - $168.37 $395,782 - $451,231
-2,680 Reduced 57.14%
2,010 $314,000
Q3 2017

Nov 03, 2017

BUY
$150.32 - $166.46 $705,000 - $780,697
4,690
4,690 $729,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $42.6B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.